BALs are prognostic biomarkers and correlate with malignant behaviors in breast cancer
Abstract Background The B-aggressive lymphoma (BAL) proteins, including BAL1, BAL2, and BAL3, constitute a conserved protein family characterized by their N-terminal macro domains and putative C-terminal poly (ADP-ribose) polymerase (PARP) active site. Dysregulation of BALs has been closely associat...
Saved in:
| Main Authors: | Xuehao Zhou, Yu Wang, Qingling Xu, Xiang Ao, Mengmeng Chen, Bingqiang Zhang, Ying Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14576-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNAJC24 suppresses breast cancer malignancy and serves as a prognostic biomarker
by: Wenjing Meng, et al.
Published: (2025-07-01) -
PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes
by: Mingjing Meng, et al.
Published: (2025-03-01) -
Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas
by: Safaa M. Ramadan
Published: (2021-02-01) -
UNC93B1: a novel immune−related prognostic biomarker in breast cancer
by: Lv Tian, et al.
Published: (2025-07-01) -
BEND4: a novel prognostic biomarker in diffuse large B-cell lymphoma
by: Yanfang Wang, et al.
Published: (2025-05-01)